Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I)

Cell Transplantation

Volumn 21, Issue 7, 2012, Pages 1577-1593

  Nan, Zhenhong ^a   Shekels, Laurie ^b   Ryabinin, Oleg ^a   Evavold, Carrie ^a   Nelson, Matthew S ^b   Khan, Shaukat A ^b   Deans, Robert J ^c   Mays, Robert W ^c   Low, Walter C ^a   Gupta, Pankaj ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

^c ATHERSYS INC   (United States)

Author keywords

Glycosaminoglycans (GAGs); Mucopolysaccharidosis I (MPS I); Proteoglycans; Stem cells; Transplantation

Indexed keywords

GLYCOSAMINOGLYCAN; LEVO IDURONIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LATERAL VENTRICLE; BRAIN LEVEL; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HURLER SYNDROME; MALE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; TISSUE DISTRIBUTION;

EID: 84930472237     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X636894     Document Type: Article

References (64)

1. Aranda, P.; Agirre, X.; Ballestar, E.; Andreu, E. J.; Roman-Gomez, J.; Prieto, I.; Martin-Subero, J. I.; Cigudosa, J. C.; Siebert, R.; Esteller, M.; Prosper, F. Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 4(11):e7809; 2009.
2. Aranguren, X. L.; McCue, J. D.; Hendrickx, B.; Zhu, X. H.; Du, F.; Chen, E.; Pelacho, B.; Penuelas, I.; Abizanda, G.; Uriz, M.; Frommer, S. A.; Ross, J. J.; Schroeder, B. A.; Seaborn, M. S.; Adney, J. R.; Hagenbrock, J.; Harris, N. H.; Zhang, Y.; Zhang, X.; Nelson-Holte, M. H.; Jiang, Y.; Billiau, A. D.; Chen, W.; Prosper, F.; Verfaillie, C. M.; Luttun, A. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J. Clin. Invest. 118(2):505-514; 2008.
3. Aronovich, E. L.; Bell, J. B.; Khan, S. A.; Belur, L. R.; Gunther, R.; Koniar, B.; Schachern, P. A.; Parker, J. B.; Carlson, C. S.; Whitley, C. B.; Mclvor, R. S.; Gupta, P.; Hackett, P. B. Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty trans-poson system. Mol. Ther. 17(7):1136-1144; 2009.
4. Auletta, J. J.; Cooke, K. R.; Solchaga, L. A.; Deans, R. J.; Van't Hof, W. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: Current impact and future directions. Biol. Blood Marrow Transplant. 16(7): 891-906; 2010.
5. Azizi, S. A.; Stokes, D.; Augelli, B. J.; DiGirolamo, C.; Prockop, D. J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95(7):3908-3913; 1998.
6. Bjoraker, K. J.; Delaney, K.; Peters, C.; Krivit, W.; Shapiro, E. G. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J. Dev. Behav. Pediatr. 27(4):290-296; 2006.
7. Bjugstad, K. B.; Teng, Y. D.; Redmond, Jr., D. E.; Elsworth, J. D.; Roth, R. H.; Cornelius, S. K.; Snyder, E. Y.; Sladek, Jr., J. R. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp. Neurol. 211(2):362-369; 2008.
8. Boozer, S.; Lehman, N.; Lakshmipathy, U.; Love, B.; Raber, A.; Maitra, I.; Deans, R.; Rao, M. S.; Ting, A. E. Global characterization and genomic stability of human MultiStem, a multipotent adult progenitor cell. J. Stem Cells 4(1):17-28; 2009.
9. Borlongan, C. V.; Kaneko, Y.; Maki, M.; Yu, S. J.; Ali, M.; Allickson, J. G.; Sanberg, C. D.; Kuzmin-Nichols, N.; Sanberg, P. R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cell Dev. 19(4):439-452; 2010.
10. Burt, R. K.; Loh, Y.; Pearce, W.; Beohar, N.; Barr, W. G.; Craig, R.; Wen, Y.; Rapp, J. A.; Kessler, J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. J. Am. Med. Assoc. 299(8): 925-936; 2008.
11. Croitoru-Lamoury, J.; Williams, K. R.; Lamoury, F. M.; Veas, L. A.; Ajami, B.; Taylor, R. M.; Brew, B. J. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy 8(5):445-458; 2006.
12. Ellinwood, N. M.; Colle, M. A.; Weil, M. A.; Casal, M. L.; Vite, C. H.; Wiemelt, S.; Hasson, C. W.; O'Malley, T. M.; He, X.; Prociuk, U.; Verot, L.; Melniczek, J. R.; Lannon, A.; Aguirre, G. D.; Knox, V. W.; Evans, S. M.; Vanier, M. T.; Schuchman, E. H.; Walkley, S. U.; Haskins, M. E. Bone marrow transplantation for feline mucopolysaccharidosis I. Mol. Genet. Metab. 91(3):239-250; 2007.
13. Ellinwood, N. M.; Vite, C. H.; Haskins, M. E. Gene therapy for lysosomal storage diseases: The lessons and promise of animal models. J. Gene Med. 6(5):481-506; 2004.
14. Fujimoto, S. T.; Longhi, L.; Saatman, K. E.; Conte, V.; Stocchetti, N.; McIntosh, T. K. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci. Biobehav. Rev. 28:365-378; 2004.
15. Garbuzova-Davis, S.; Klasko, S. K.; Sanberg, P. R. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. J. Comp. Neurol. 515(1):93-101; 2009.
16. Garbuzova-Davis, S.; Willing, A. E.; Desjarlais, T.; Davis Sanberg, C.; Sanberg, P. R. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cell Dev. 14(4):384-394; 2005.
17. Garcia-Rivera, M. F.; Colvin-Wanshura, L. E.; Nelson, M. S.; Nan, Z.; Khan, S. A.; Rogers, T. B.; Maitra, I.; Low, W. C.; Gupta, P. Characterization of an immunode-ficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy. Brain Res. Bull. 74(6):429-438; 2007.
18. Giordano, A.; Galderisi, U.; Marino, I. R. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 211(1):27-35; 2007.
19. Gupta, P.; Brazil, J. J.; Reyes, M.; Verfaillie, C. M. Human bone marrow derived mesodermal progenitor cells (MPC) in vitro correct the biochemical abnormality in Hurler syndrome. Blood 96(11):279a; 2000.
20. Haskins, M. E. Animal models for mucopolysaccharidosis disorders and their clinical relevance. Acta Paediatr. Suppl. 96(455):56-62; 2007.
21. Jahagirdar, B. N.; Verfaillie, C. M. Multipotent adult progenitor cell and stem cell plasticity. Stem Cell Rev. 1(1): 53-59; 2005.
22. Jiang, Y.; Henderson, D.; Blackstad, M.; Chen, A.; Miller, R. F.; Verfaillie, C. M. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl. Acad. Sci. USA 100(Suppl. 1):11854-11860; 2003.
23. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-49; 2002.
24. Kaemmerer, W. F.; Low, W. C. Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1. Exp. Neurol. 158(2):301-311; 1999.
25. Kakkis, E. D.; Schuchman, E.; He, X.; Wan, Q.; Kania, S.; Wiemelt, S.; Hasson, C. W.; O'Malley, T.; Weil, M. A.; Aguirre, G. A.; Brown, D. E.; Haskins, M. E. Enzyme replacement therapy in feline mucopolysaccharidosis I. Mol. Genet. Metab. 72(3):199-208; 2001.
26. Keene, C. D.; Ortiz-Gonzalez, X. R.; Jiang, Y.; Largaespada, D. A.; Verfaillie, C. M.; Low, W. C. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant. 12(3): 201-213; 2003.
27. Killedar, S.; Dirosario, J.; Divers, E.; Popovich, P. G.; McCarty, D. M.; Fu, H. Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J. Neuroinflamm. 7:39; 2010.
28. Lee, J. P.; Jeyakumar, M.; Gonzalez, R.; Takahashi, H.; Lee, P. J.; Baek, R. C.; Clark, D.; Rose, H.; Fu, G.; Clarke, J.; McKercher, S.; Meerloo, J.; Muller, F. J.; Park, K. I.; Butters, T. D.; Dwek, R. A.; Schwartz, P.; Tong, G.; Wenger, D.; Lipton, S. A.; Seyfried, T. N.; Platt, F. M.; Snyder, E. Y. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med. 13(4):439-447; 2007.
29. Lee, S. T.; Chu, K.; Kim, E. H.; Jung, K. H.; Lee, K. B.; Sinn, D. I.; Kim, S. U.; Kim, M.; Roh, J. K. Quantification of human neural stem cell engraftments in rat brains using ERV-3 real-time PCR. J. Neurosci. Methods 157(2):225-229; 2006.
30. Li, H. H.; Zhao, H. Z.; Neufeld, E. F.; Cai, Y.; Gomez-Pinilla, F. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J. Neurosci. Res. 69(1):30-38; 2002.
31. Lindvall, O.; Kokaia, Z. Stem cells in human neurodegen-erative disorders-time for clinical translation? J. Clin. Invest. 120(1):29-40; 2010.
32. Lyon, G.; Adams, R. D.; Kolodny, E. H. Late infantile progressive genetic encephalopathies. In: Lyon, G.; Adams, R. D.; Kolodny, E. H., eds. Neurology of hereditary metabolic diseases of children. New York, NY: McGraw Hill; 1996:124-176.
33. Mays, R. W.; Borlongan, C. V.; Yasuhara, T.; Hara, K.; Maki, M.; Carroll, J. E.; Deans, R. J.; Hess, D. C. Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke. J. Exp. Stroke Transl. Med. 3(1):34-46; 2010.
34. McKenzie, J. L.; Gan, O. I.; Doedens, M.; Dick, J. E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplant into NOD/ SCID recipients depleted of CD122+ cells. Blood 106: 1259-1261; 2005.
35. Meyerrose, T. E.; Roberts, M.; Ohlemiller, K. K.; Vogler, C. A.; Wirthlin, L.; Nolta, J. A.; Sands, M. S. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 26(7):1713-1722; 2008.
36. Muenzer, J.; Wraith, J. E.; Clarke, L. A. Mucopolysaccharidosis I: Management and treatment guidelines. Pediatrics 123(1):19-29; 2009.
37. Neufeld, E. F.; Muenzer, J. The mucopolysaccharidoses. In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D.; Childs, B.; Kinzler, K. W.; Vogelstein, B., eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 2001:3421-3452.
38. Ohmi, K.; Greenberg, D. S.; Rajavel, K. S.; Ryazantsev, S.; Li, H. H.; Neufeld, E. F. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl. Acad. Sci. USA 100:1902-1907; 2003.
39. Park, D. H.; Eve, D. J.; Musso, 3rd., J.; Klasko, S. K.; Cruz, E.; Borlongan, C. V.; Sanberg, P. R. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cell Dev. 18(5):693-702; 2009.
40. Perry, R.; Miller, D.; Deans, R. Clinical scale expansion of human pluripotent stem cells. Blood 106(11):1060; 2005.
41. Peters, C.; Balthazor, M.; Shapiro, E. G.; King, R. J.; Kollman, C.; Hegland, J. D.; Henslee-Downey, J.; Trigg, M. E.; Cowan, M. J.; Sanders, J.; Bunin, N.; Weinstein, H.; Lenarsky, C.; Falk, P.; Harris, R.; Bowen, T.; Williams, T. E.; Grayson, G. H.; Warkentin, P.; Sender, L.; Cool, V. A.; Crittenden, M.; Packman, S.; Kaplan, P.; Lockman, L. A.; Anderson, J.; Krivit, W.; Dusenbery, K.; Wagner, J. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87(11):4894-4902; 1996.
42. Peters, C.; Shapiro, E. G.; Anderson, J.; Henslee-Downey, P. J.; Klemperer, M. R.; Cowan, M. J.; Saunders, E. F.; deAlarcon, P. A.; Twist, C.; Nachman, J. B.; Hale, G. A.; Harris, R. E.; Rozans, M. K.; Kurtzberg, J.; Grayson, G. H.; Williams, T. E.; Lenarsky, C.; Wagner, J. E.; Krivit, W. Hurler syndrome: II. Outcome of HLA-geno-typically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91(7):2601-2608; 1998.
43. Peters, C.; Shapiro, E. G.; Krivit, W. Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr. Transplant. 2(4):250-253; 1998.
44. Ponder, K. P.; Haskins, M. E. Gene therapy for mucopolysaccharidosis. Expert Opin. Biol. Ther. 7(9):1333-1345; 2007.
45. Prasad, V. K.; Kurtzberg, J. Transplant outcomes in mucopolysaccharidoses. Semin. Hematol. 47(1):59-69; 2010.
46. Sanberg, P. R.; Eve, D. J.; Willing, A. E.; Garbuzova-Davis, S.; Tan, J.; Sanberg, C. D.; Allickson, J. G.; Borlongan, C. V. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant. 20(1):85-94; 2011.
47. Schuchman, E. H.; Guzman, N. A.; Desnick, R. J. Human alpha-L-iduronidase. I. Purification and properties of the high uptake (higher molecular weight) and the low uptake (processed) forms. J. Biol. Chem. 259(5):3132-3140; 1984.
48. Shultz, L. D.; Schweitzer, P. A.; Christianson, S. W.; Gott, B.; Schweitzer, I. B.; Tennent, B.; McKenna, S.; Mobraaten, L.; Rajan, T. V.; Greiner, D. L.; Leiter, E. H. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154(1): 180-191; 1995.
49. Sidman, R. L.; Li, J.; Stewart, G. R.; Clarke, J.; Yang, W.; Snyder, E. Y.; Shihabuddin, L. S. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice. Brain Res. 1140:195-204; 2007.
50. Singec, I.; Jandial, R.; Crain, A.; Nikkhah, G.; Snyder, E. Y. The leading edge of stem cell therapeutics. Annu. Rev. Med. 58:313-328; 2007.
51. Snyder, E. Y.; Taylor, R. M.; Wolfe, J. H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374(6520):367-370; 1995.
52. Staba, S. L.; Escolar, M. L.; Poe, M.; Kim, Y.; Martin, P. L.; Szabolcs, P.; Allison-Thacker, J.; Wood, S.; Wenger, D. A.; Rubinstein, P.; Hopwood, J. J.; Krivit, W.; Kurtzberg, J. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N. Engl. J. Med. 350(19):1960-1969; 2004.
53. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872; 2007.
54. Taylor, R. M.; Lee, J. P.; Palacino, J. J.; Bower, K. A.; Li, J.; Vanier, M. T.; Wenger, D. A.; Sidman, R. L.; Snyder, E. Y. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: Evidence from a mouse model of Krabbe leukodystrophy. J. Neurochem. 97(6):1585-1599; 2006.
55. Walker, P. A.; Shah, S. K.; Jimenez, F.; Gerber, M. H.; Xue, H.; Cutrone, R.; Hamilton, J. A.; Mays, R. W.; Deans, R.; Pati, S.; Dash, P. K.; Cox, Jr., C. S. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes. Exp. Neurol. 225(2):341-352; 2010.
56. Walkley, S. U. Cellular pathology of lysosomal storage disorders. Brain Pathol. 8(1):175-193; 1998.
57. Walkley, S. U. Pathogenic cascades in lysosomal dis-ease-Why so complex? J. Inherit. Metab. Dis. 32(2): 181-189; 2009.
58. Walkley, S. U. Pathogenic mechanisms in lysosomal disease: A reappraisal of the role of the lysosome. Acta Paediatr. Suppl. 96(455):26-32; 2007.
59. Walkley, S. U.; Haskins, M. E.; Shull, R. M. Alterations in neuron morphology in mucopolysaccharidosis type I. A Golgi study. Acta Neuropathol. 75(6):611-620; 1988.
60. Whitley, C. B. The mucopolysaccharidoses. In: Moser, H. W., ed. Neurodystrophies and neurolipidoses. Amsterdam, The Netherlands: Elsevier Science; 1996:281-328.
61. Yasuhara, T.; Hara, K.; Maki, M.; Mays, R. W.; Deans, R. J.; Hess, D. C.; Carroll, J. E.; Borlongan, C. V. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J. Cereb. Blood Flow Metab. 28(11):1804-1810; 2008.
62. Yasuhara, T.; Matsukawa, N.; Yu, G.; Xu, L.; Mays, R. W.; Kovach, J.; Deans, R. J.; Hess, D. C.; Carroll, J. E.; Borlongan, C. V. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant. 15(3): 231-238; 2006.
63. Zhao, L. R.; Duan, W. M.; Reyes, M.; Keene, C. D.; Verfaillie, C. M.; Low, W. C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174(1):11-20; 2002.
64. Zhao, L. R.; Duan, W. M.; Reyes, M.; Verfaillie, C. M.; Low, W. C. Immunohistochemical identification of multi-potent adult progenitor cells from human bone marrow after transplantation into the rat brain. Brain Res. 11(1): 38-45; 2003.